Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

External Validation of EHR-CAT Risk Assessment Model for Cancer Associated Thrombosis in 150 Healthcare Organizations

Ang Li, Rockbum Kim, Omid Jafari, Shengling Ma, Jun Yang Jiang, Nathanael R. Fillmore, Jennifer La, Christopher I Amos

Blood (2024) 144 (Supplement 1): 812.

https://doi.org/10.1182/blood-2024-202183

Published: 2024

Journal Articles

Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems

Geethika Bodanapu, June Corrigan, John Culnan, Maya Srinivasan, Mehar Hora, Alexander Lazzaro, Cenk Yildirim, Danne Elbers, Deborah Lang, Nhan V. Do, Mary T. Brophy, Britney Bell, Raphael E. Szalat, Nikhil C. Munshi, Nathanael R. Fillmore, Camille V. Edwards

Blood (2024) 144 (Supplement 1): 3341.

https://doi.org/10.1182/blood-2024-198815

Published: 2024

Journal Articles

Evaluation of Socioeconomic Barriers Impacting Patients with Newly Diagnosed Multiple Myeloma

Maya D. Srinivasan, John Culnan, Mehar Hora, Alexander Lazzaro, Britney Bell, Geethika Bodanapu, Cenk Yildirim, June Corrigan, Nhan V. Do, Mary T. Brophy, Nikhil C. Munshi, Raphael E. Szalat, Nathanael R. Fillmore, Camille V. Edwards

Blood (2024) 144 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2024-211465

Published: 2024

Journal Articles

Circulating Tumor DNA Predicts Venous Thromboembolism in Minority Patients with Cancers

Shengling Ma, Jun Yang Jiang, Rockbum Kim, Elizabeth Chiang, Joyce Tiong, Justine Ryu, Danielle Guffey, Raka Bandyo, Heidi Dowst, Kaitlin N Swinnerton, Nathanael R. Fillmore, Jennifer La, Ang Li

Blood (2024) 144 (Supplement 1): 4013.

https://doi.org/10.1182/blood-2024-201751

Published: 2024

Journal Articles

Retrospective Review of Care for Black/African American Veterans with Multiple Myeloma at the Orlando VA

Joane Titus, Allison Carilli, Nathanael R. Fillmore

Blood (2024) 144 (Supplement 1): 7002.

https://doi.org/10.1182/blood-2024-211995

Published: 2024

Journal Articles

Optimized Multi-Class VTE-BERT Large Language Model for Prediction of Cancer Associated Thrombosis Phenotype

Ang Li, Omid Jafari, Shengling Ma, Arash Maghsoudi, Barbara D Lam, Justine Ryu, Jun Yang Jiang, Mrinal Ranjan, Emily Zhou, Raka Bandyo, Bo Peng, Christopher I Amos, Nathanael R. Fillmore, Abiodun O. Oluyomi, Jennifer La

Blood (2024) 144 (Supplement 1): 161.

https://doi.org/10.1182/blood-2024-202180

Published: 2024

Journal Articles

Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma

Grace M. Ferri, Cenk Yildirim, Joseph Park, Nhan V. Do, Mary T. Brophy, Nikhil C. Munshi, Camille V. Edwards, Nathanael R. Fillmore

Blood (2024) 144 (Supplement 1): 6930.

https://doi.org/10.1182/blood-2024-206352

Published: 2024

Journal Articles

Development of Novel Peripheral Blood Count-Based Prognostic Index for Multiple Myeloma

Grace M. Ferri, Cenk Yildirim, Joseph Park, Nhan V. Do, Mary T. Brophy, Nikhil C. Munshi, Nathanael R. Fillmore, Camille V. Edwards

Blood (2024) 144 (Supplement 1): 6981.

https://doi.org/10.1182/blood-2024-206313

Published: 2024

Journal Articles

Implementation of Automated Thrombosis and Bleeding Risk Assessment in Cancer Patients Undergoing Systemic Therapy

Ang Li, Shengling Ma, Raka Bandyo, Mrinal Ranjan, Elizabeth Chiang, Joyce Tiong, Jun Yang Jiang, Justine Ryu, Omid Jafari, Christopher I Amos, Nathanael R. Fillmore, Jennifer La, Karlyn A. Martin, Chirayu J Shah, Aparna Jotwani

Blood (2024) 144 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2024-211372

Published: 2024

Journal Articles

Racial/Ethnic Disparity for Hematologic Malignancies in Different Healthcare Systems in the U.S

Rockbum Kim, Emily Zhou, Kaitlin N Swinnerton, Danielle Guffey, Shengling Ma, Raka Bandyo, Arash Maghsoudi, Omar Rosales, Abiodun O. Ouyomi, Nhan V Do, Mary T Brophy, Jennifer La, Nathanael R Fillmore, Ang Li

Blood (2023) 142 (Supplement 1): 493.

https://doi.org/10.1182/blood-2023-180901

Published: 2023

Journal Articles

Psychiatric and Substance Use Disorders Are Independent Predictors of Treatment Response and Outcomes in United States Veterans with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Combinations

Michelle Hyunju Lee, Jennifer La, Mary T Brophy, Nhan V Do, Camille V. Edwards, Clark Dumontier, Gabriela S. Hobbs, Nathanael R Fillmore

Blood (2023) 142 (Supplement 1): 388.

https://doi.org/10.1182/blood-2023-180915

Published: 2023

Journal Articles

Development and External Validation of a Lymphoma-Specific Venous Thromboembolism Risk Assessment Model

Shengling Ma, Kaitlin N Swinnerton, Jennifer La, Danielle Guffey, Raka Bandyo, Christopher I Amos, Vipul Chitalia, Giordana De Las Pozas, Katy M Toale, Xiangjun Xiao, Cristhiam M. Rojas Hernandez, Katya Ravid, Kelly Merriman, Christopher R. Flowers, Nathanael R Fillmore, Ang Li

Blood (2023) 142 (Supplement 1): 565.

https://doi.org/10.1182/blood-2023-184770

Published: 2023

Journal Articles

Overall Survival of Warfarin Compared to LMWH/Doacs in Cancer-Associated Venous Thromboembolism: VA Cohort Study

Justine Ryu, Jennifer La, Rushad Patell, Ang Li, Nhan V Do, Mary T Brophy, Nathanael R Fillmore, Jeffrey I. Zwicker

Blood (2023) 142 (Supplement 1): 138.

https://doi.org/10.1182/blood-2023-187297

Published: 2023

Journal Articles

Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy

Hamza Hassan, June Corrigan, Nathanael R Fillmore, Jennifer La, Nhan V Do, Mary Brophy, Nikhil C Munshi

Blood (2022) 140 (Supplement 1): 12587–12588.

https://doi.org/10.1182/blood-2022-170811

Published: 2022

Journal Articles

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study

Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Paul Monach, Mary Brophy, Nhan V Do, Nikhil C Munshi

Blood (2022) 140 (Supplement 1): 4297–4298.

https://doi.org/10.1182/blood-2022-169559

Published: 2022

Journal Articles

Baseline Correlates of Frailty and Its Association with Survival in U.S. Veterans with Newly Diagnosed and Treated Acute Myeloid Leukemia

Michelle Hyunju Lee, Jennifer La, Mary Brophy, Nhan V Do, Jane A. Driver, David P Tuck, Nathanael R Fillmore, Clark Dumontier

Blood (2022) 140 (Supplement 1): 8117–8118.

https://doi.org/10.1182/blood-2022-169225

Published: 2022

Journal Articles

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S. Han, Mary Brophy, Nhan V. Do, Albert Y. Lin, Nathanael R. Fillmore, Nikhil C. Munshi

Blood (2022) 140 (7): 782–785.

https://doi.org/10.1182/blood.2022016317

Published: 2022

Journal Articles

Peripheral Blood Monocyte Count Is a Strong, Dynamic Prognostic Biomarker for Risk Stratification in Multiple Myeloma

Camille V Edwards, Hamza Hassan, Grace Ferri, Karina Verma, Cenk Yildirim, Nathanael R Fillmore, Nikhil C. Munshi

Blood (2021) 138 (Supplement 1): 3769.

https://doi.org/10.1182/blood-2021-149637

Published: 2021

Journal Articles

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study

Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, Giovanni Parmigiani, David P Tuck, Mary Brophy, Nhan V Do, Albert Y Lin, Nikhil C. Munshi

Blood (2021) 138 (Supplement 1): 400.

https://doi.org/10.1182/blood-2021-154323

Published: 2021

Journal Articles

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Nathanael R. Fillmore, Sarvari V. Yellapragada, Chizoba Ifeorah, Ansh Mehta, Diana Cirstea, Paul S. White, Gustavo Rivero, Andrew Zimolzak, Saiju Pyarajan, Nhan Do, Mary Brophy, Nikhil C. Munshi

Blood (2019) 133 (24): 2615–2618.

https://doi.org/10.1182/blood.2019000406

Published: 2019

NARROW

External Validation of EHR-CAT Risk Assessment Model for Cancer Associated Thrombosis in 150 Healthcare Organizations

Risk Factors for Suboptimal Treatment in Patients with Newly Diagnosed Multiple Myeloma across US Healthcare Systems

Evaluation of Socioeconomic Barriers Impacting Patients with Newly Diagnosed Multiple Myeloma

Circulating Tumor DNA Predicts Venous Thromboembolism in Minority Patients with Cancers

Retrospective Review of Care for Black/African American Veterans with Multiple Myeloma at the Orlando VA

Optimized Multi-Class VTE-BERT Large Language Model for Prediction of Cancer Associated Thrombosis Phenotype

Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma

Development of Novel Peripheral Blood Count-Based Prognostic Index for Multiple Myeloma

Implementation of Automated Thrombosis and Bleeding Risk Assessment in Cancer Patients Undergoing Systemic Therapy

Racial/Ethnic Disparity for Hematologic Malignancies in Different Healthcare Systems in the U.S

Psychiatric and Substance Use Disorders Are Independent Predictors of Treatment Response and Outcomes in United States Veterans with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Combinations

Development and External Validation of a Lymphoma-Specific Venous Thromboembolism Risk Assessment Model

Overall Survival of Warfarin Compared to LMWH/Doacs in Cancer-Associated Venous Thromboembolism: VA Cohort Study

Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy

Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study

Baseline Correlates of Frailty and Its Association with Survival in U.S. Veterans with Newly Diagnosed and Treated Acute Myeloid Leukemia

Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Peripheral Blood Monocyte Count Is a Strong, Dynamic Prognostic Biomarker for Risk Stratification in Multiple Myeloma

Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only